Swedbank’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.8M Buy
12,500
+2,000
+19% +$1.17M 0.01% 531
2026
Q2
$5.56M Sell
10,500
-1,500
-13% -$692K ﹤0.01% 576
2026
Q1
$5.76M Sell
12,000
-10,000
-45% -$5.12M 0.01% 556
2025
Q4
$12.4M Sell
22,000
-36,000
-62% -$20.4M 0.01% 467
2025
Q3
$29.8M Sell
58,000
-13,000
-18% -$5.68M 0.03% 306
2025
Q2
$22.3M Buy
71,000
+3,000
+4% +$901K 0.03% 345
2025
Q1
$20.7M Sell
68,000
-9,400
-12% -$3.16M 0.03% 344
2024
Q4
$25.7M Buy
77,400
+55,000
+246% +$18.7M 0.03% 304
2024
Q3
$7.48M Buy
+22,400
New +$8.51M 0.01% 489

Other funds holding MEDP

Swedbank's MEDP Position: Q3 2026 in Review

Swedbank increased its Medpace (MEDP) stake by 19% in Q3 2026, buying an estimated $1.17M and bringing the position to 12,500 shares worth $7.8M. The position accounts for 0.01% of the portfolio, ranked #531.

Swedbank first reported a position in MEDP in Q3 2024 and has held it in 9 quarters since. The position peaked at $29.8M in Q3 2025. 234 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Swedbank held 12,500 shares of Medpace worth $7.8M as of Q3 2026.
  • Swedbank bought 2,000 Medpace shares in Q3 2026, an estimated $1.17M.
  • Medpace made up 0.01% of Swedbank's portfolio in Q3 2026, its #531 holding.
  • Swedbank first reported a position in Medpace in Q3 2024 and has held it in 9 quarters since.
  • Swedbank's Medpace position peaked at $29.8M in Q3 2025.
  • 234 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Swedbank's 13F filing for Q3 2026, filed 27 Oct 2026.